dc.contributor.author
Schleusener, Johannes
dc.contributor.author
Lohan, Silke B.
dc.contributor.author
Busch, Loris
dc.contributor.author
Ghoreschi, Kamran
dc.contributor.author
Ploch, Neysha Lobo
dc.contributor.author
May, Stefanie
dc.contributor.author
Vogel, Simone
dc.contributor.author
Eberle, Jürgen
dc.contributor.author
Meinke, Martina C.
dc.date.accessioned
2025-03-28T15:36:10Z
dc.date.available
2025-03-28T15:36:10Z
dc.identifier.uri
https://refubium.fu-berlin.de/handle/fub188/47078
dc.identifier.uri
http://dx.doi.org/10.17169/refubium-46795
dc.description.abstract
Fungal infections have increased considerably over the last decades, becoming progressively resistant to common drugs. UVC light has shown microbiological eradication effects, whereby the wavelength of 254 nm is strongly carcino- and mutagenic. Therefore, 222 and 233 nm, which do not significantly harm skin cells, were tested for their antifungal effects. Microbicidal doses were reached at 40 mJ/cm(2) for both wavelengths, resulting in only minor superficial skin damage (<20 mu m). UVC irradiation with far-UVC <240 nm represents a new opportunity to effectively eradicate even larger pathogens on tissue causing no or strongly reduced DNA and tissue damage.
en
dc.rights.uri
https://creativecommons.org/licenses/by-nc-nd/4.0/
dc.subject
233 nm UVC LED
en
dc.subject
clinical application
en
dc.subject
disinfection
en
dc.subject
fungal infections
en
dc.subject.ddc
600 Technik, Medizin, angewandte Wissenschaften::610 Medizin und Gesundheit::610 Medizin und Gesundheit
dc.title
Treatment of the Candida subspecies Candida albicans and Candida parapsilosis with two far-UVC sources to minimise mycoses in clinical practice
dc.type
Wissenschaftlicher Artikel
dcterms.bibliographicCitation.doi
10.1111/myc.13521
dcterms.bibliographicCitation.journaltitle
Mycoses
dcterms.bibliographicCitation.number
1
dcterms.bibliographicCitation.originalpublishername
Wiley
dcterms.bibliographicCitation.pagestart
25
dcterms.bibliographicCitation.pageend
28
dcterms.bibliographicCitation.volume
66
refubium.affiliation
Charité - Universitätsmedizin Berlin
refubium.funding
DEAL Wiley
refubium.resourceType.isindependentpub
no
dcterms.accessRights.openaire
open access
dcterms.bibliographicCitation.pmid
35986595
dcterms.isPartOf.issn
0933-7407
dcterms.isPartOf.eissn
1439-0507